Mitoxantrone Hydrochloride Pharmaceutical and Health Care Products
Listing of Mitoxantrone Hydrochloride pharmaceutical drugs and health products:
- Domitrone (Biomedis Oncology; United Laboratories)
- Elsep (Wyeth; Meda)
- Elsep (Wyeth; Meda)
- Formyxan (Pisa Laboratorios)
- Genefadron (Genepharma Group; Interpharm)
- Genefadrone (Genepharma Group)
- Micraleve (IVAX)
- Misostol (Zodiac Produtos Farmaceuticos)
- Mitaxis (Itaca Laboratorios)
- Mitoxal (Asta Medica)
- Mitoxan (ADiPharm)
- Mitoxantron (Ebewe)
- Mitoxantron (Ebewe Pharma)
- Mitoxantron (Firma Vai Hong; Sandoz; Schumit 1967; Zuellig Pharma)
- Mitoxantrona (Baxter)
- Mitoxantrone (American Pharmaceutical Partners)
- Mitoxantrone (Ebewe)
- Mitoxantrone (Fresenius)
- Mitoxantrone (Generamedix)
- Mitoxantrone (Hospira)
- Mitoxantrone (Jelfa Pharmaceuticals Works; Polfa Ciech)
- Mitoxantrone (Mayne Pharma)
- Mitoxantrone (Merck)
- Mitoxantrone (Mylan Pharmaceuticals)
- Mitoxantrone (Novopharm)
- Mitoxantrone (Pharmaceutical Partners of Canada)
- Mitoxantrone (Sicor Pharmaceuticals)
- Mitoxantrone (Teva)
- Mitoxantrone (Wockhardt)
- Mitoxantrone (APP Pharmaceuticals)
- Mitoxantrone (Baxter; Zuellig Pharma)
- Mitoxantrone (Ebewe Pharma)
- Mitoxantrone (Ever Neuro Pharma)
- Mitoxantrone (Jelfa Pharmaceuticals Works)
- Mitoxantrone (Mylan)
- Mitoxgen (Armstrong Laboratorios de Mexico; Bioprofarma)
- Mitoxgen (Armstrong Laboratorios de Mexico; Bioprofarma; Sinensix Pharma)
- Mitroxone (Columbia Laboratorios)
- Neotalem (Teva; Chile Laboratorios; Lemery)
- Neotalem (Teva; Chile Laboratorios; Lemery)
- Novantron (Wyeth; AHP Schweiz; Meda)
- Novantron (Wyeth; AHP Schweiz; Meda)
- Novantrone (Wyeth; Dexxon; Immunex; Meda; Neopharm, Israel; Serono; Sigma Pharmaceuticals; Zuellig Pharma)
- Novantrone (Wyeth; Dexxon; Immunex; Meda; Neopharm, Israel; Serono; Sigma Pharmaceuticals; Zuellig Pharma)
- Onkotrone (Baxter; Pliva)
- Onkotrone (Baxter; Pliva)
- Pralifan (Inibsa Laboratorios)
- Ralenova (Wyeth)
- Refador (Pliva)
- Santrone (Korea United Pharmaceutical; HealthCare PharmaScience; Via Hong)
1